Danish chemical industry news (page 3)

• 

  10 November 2025

  RWE Installs Recyclable Blades, Over Half of Turbines at Sofia Offshore Wind Farm

  Sofia Offshore Wind Farm progresses with 60% of turbines installed. Recyclable blades mark UK's first large-scale deployment, aiming for full operation by September 2026.
• 

  8 November 2025

  Novo Nordisk Won't Raise Metsera Acquisition Offer

  Novo Nordisk maintains its offer for Metsera, citing financial discipline and strategic goals, despite previous revisions and competitive considerations.
• 

  6 November 2025

  Novo Nordisk's CagriSema Reduces Blood Pressure and Inflammation, Lowers Heart Disease Risk

  CagriSema shows potential in reducing blood pressure, inflammation, and heart disease risk, with ongoing trials to assess cardiovascular outcomes.
• 

  5 November 2025

  Novo Nordisk's Wegovy® Helps Users Meet Health Targets, Reducing Obesity Risks

  Wegovy® users achieved BMI and waist targets, improving cardiovascular health and reducing obesity-related risks, as shown in the STEP UP trial.
• 

  5 November 2025

  Novo Nordisk Unveils New Oral Semaglutide Analyses at ObesityWeek 2025

  Oral semaglutide 25 mg shows improved blood sugar control, cardiovascular risk factors, and weight loss efficacy, comparable to injectable form, across various patient groups.
• 

  5 November 2025

  EU Transport Package: High-Speed Rail and Sustainable Fuel Initiatives

  The EU aims to enhance rail connectivity and boost investment in renewable fuels for aviation and waterborne sectors, promoting sustainability and competitiveness.

• 

  30 October 2025

  Topsoe Opens Europe's Largest SOEC Facility

  The new facility in Denmark will produce high-efficiency electrolyzers for green hydrogen, aiding industrial decarbonization and supported by EU funding.
• 

  29 October 2025

  Baltic Power Installs Key Offshore Substations

  Two offshore substations installed to transmit wind-generated electricity to Poland's grid, with significant local manufacturing involvement. Completion set for next year, providing 1.2 GW capacity.
• 

  29 October 2025

  Ørsted and Worley Sign Long-Term EPCM Agreement

  The eight-year deal supports power generation and CCS in Denmark, enhancing energy infrastructure and decarbonization efforts with a focus on safety and sustainability.
• 

  28 October 2025

  Topsoe's SOEC Technology Chosen for Forestal's E-Methanol Project

  Topsoe's SOEC tech will power Forestal's Triskelion e-methanol project in Spain, enhancing efficiency and sustainability, with operations set for 2028.
• 

  23 October 2025

  BASF and ANDRITZ License Agreement for OASE Technology

  OASE technology to capture 435,000 tons of CO2 annually in Aarhus waste-to-energy plant, pending Danish CCS fund approval.
• 

  20 October 2025

  Novo Nordisk to Present Oral Semaglutide and Obesity Data at ObesityWeek 2025

  New data on oral semaglutide and CagriSema will be presented, focusing on weight loss efficacy, cardiometabolic health, and women's health in obesity management.
• 

  15 October 2025

  Novo Nordisk Acquires Rights to Omeros' MASP-3 Inhibitor Zaltenibart

  Zaltenibart, a MASP-3 inhibitor, targets rare blood and kidney disorders. Omeros receives up to $2.1 billion, plus royalties. Novo Nordisk plans global phase 3 trials.
• 

  9 October 2025

  Novo Nordisk Acquires Akero Therapeutics to Enhance MASH Treatment Portfolio

  Novo Nordisk acquires Akero for $4.7B, adding efruxifermin, a promising MASH treatment, to its portfolio. The deal includes a $0.5B contingent value right upon regulatory approval.
• 

  9 October 2025

  Ørsted Streamlines Workforce for Enhanced Competitiveness

  Ørsted plans to cut 2,000 jobs by 2027 to focus on offshore wind in Europe, aiming for cost savings and increased efficiency.
• 

  2 October 2025

  TotalEnergies Partners with CarbonVault in Bifrost CCS Project

  TotalEnergies and partners advance the Bifrost CCS Project, storing CO2 offshore to support decarbonization and Denmark's CO2 storage hub ambitions. Transaction awaits regulatory approval.
• 

  29 September 2025

  Genmab Acquires Merus for $8 Billion, Boosting Pipeline

  Acquisition adds petosemtamab to Genmab's portfolio, aiming for 2027 launch. Expected to enhance growth and EBITDA by 2029.
• 

  22 September 2025

  Topsoe Advances CO2-to-Food Project to Next Phase

  A consortium progresses to phase two, optimizing CO2-to-food tech with renewed funding, aiming to create sustainable protein alternatives amid global hunger challenges.
• 

  18 September 2025

  Novo Nordisk: Ozempic® Cuts Heart Attack, Stroke, and Death Risk by 23% vs. Dulaglutide

  Ozempic® shows 26% lower death risk and 25% reduced risk of major cardiovascular events in older diabetes patients compared to dulaglutide in a real-world study.
• 

  16 September 2025

  Novo Nordisk Advances Cagrilintide to Phase 3 Clinical Program After Positive Results

  Cagrilintide shows significant weight loss and tolerability in trials, prompting further study in the RENEW phase 3 program for obesity treatment.
• 

  15 September 2025

  ORLEN Neptun Expands Świnoujście Terminal with Smulders Contract

  The Świnoujście Terminal will store and assemble components for the Baltica 2 wind farm, enhancing its role as a key hub for offshore wind projects in the Baltic region.
• 

  10 September 2025

  Novo Nordisk Restructures for Growth

  Streamlining aims to cut 9,000 jobs, save DKK 8bn annually by 2026, and reinvest in diabetes and obesity growth, despite DKK 8bn restructuring costs impacting 2025 profit outlook.
• 

  9 September 2025

  RWE Launches Drone-Based Environmental Monitoring at Kaskasi Wind Farm

  Drones and AI enhance eco-friendly monitoring of marine life at offshore wind farms, reducing emissions and improving data accuracy.
• 

  5 September 2025

  Ørsted A/S Extraordinary General Meeting Decisions

  Board authorized to increase share capital with pre-emptive rights; previous authorization without pre-emptive rights repealed; resolutions registration approved.
• 

  2 September 2025

  Dow Announces Increased Macquarie Stake in Diamond Infrastructure Solutions

  Dow receives $540M as Macquarie raises its stake in Diamond Infrastructure Solutions to 49%, enhancing their strategic partnership and expanding service offerings across multiple sectors.
• 

  2 September 2025

  Dow Announces Increased Macquarie Stake in Diamond Infrastructure Solutions

  Dow gains $540M as Macquarie raises its stake in Diamond Infrastructure Solutions to 49%, enhancing their strategic partnership and expanding service offerings across multiple sectors.
• 

  1 September 2025

  Equinor Backs Ørsted's Rights Issue

  Equinor supports Ørsted's Rights Issue to strengthen its balance sheet, maintaining a 10% stake and considering board nomination, with a potential investment of up to DKK 6 billion.
• 

  27 August 2025

  Topsoe Faces Market Challenges in H1 2025 Results

  Revenue and EBIT declined due to global uncertainties. Investments in energy transition continue, with a revised full-year outlook. SOEC facility nears readiness for green hydrogen production.
• 

  29 July 2025

  EU Approves €36M Danish Aid for Sustainable Aviation Fuel

  The scheme supports SAF use on Danish domestic flights, aiming for 40% SAF by 2027, with grants covering extra costs. It ensures cost-effectiveness and minimal competition impact.
• 

  10 July 2025

  Ørsted Secures Financing for Greater Changhua 2 Project

  Ørsted advances its strategic goals with project financing for Greater Changhua 2, supported by international banks and export credit agencies.